Tenet Healthcare stock rises 2% on earnings beat and raised guidance

Tenet Healthcare (NYSE:THC) reported Q3 2026 adjusted EPS of $6.64, beating estimates by $1.97. Revenue was $5.63B, up 6.5% YoY. The company raised full-year 2026 adjusted EBITDA guidance to $5.05B-$5.20B and adjusted free cash flow guidance to $2.825B-$3.125B. Shares rose 2.05% in pre-market trading.

Original reporting
Published Oct 29, 2026, 11:10 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 11:21 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$THC
Bullish
high confidence
Mentioned
$THC
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$THCBullishHigh
01

Why it matters

The earnings beat and guidance lift are likely to attract buying interest, supporting a near‑term price rally.

02

Market read

Strong earnings and guidance raise make THC a short‑term buying candidate.

03

What to watch

Potential headwinds from regulatory changes or payer mix shifts are not addressed in the release.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Tenet Healthcare (NYSE:THC) posted Q3 2026 results with adjusted EPS $6.64 vs $4.67 consensus and raised FY2026 EBITDA and EPS guidance.

Company-level read

Ticker impact

$THCBullishHigh confidence
Context

Tenet Healthcare reported Q3 earnings that beat estimates and raised full-year guidance, causing a 2% pre‑market price rise.

Expected impact

likely upward pressure as investors price in the improved outlook

Evidence & confidence

The beat was $1.97 above EPS consensus and guidance was raised by $195 M at the midpoint, a material improvement.

Market effects

Healthcare services sector may see modest upside as Tenet's results set a positive tone.

U.S. hospital and ambulatory‑care stocks could benefit from the guidance lift.

Limited to U.S. markets; no direct global macro effect.

Counterpoint

If the guidance raise is already priced in, the stock could face a short‑term pull‑back.

Key entities

  • Tenet Healthcare Corporation

    U.S. healthcare services provider reporting earnings.

Related articles

$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.

$THCHighAI 8/10

Mizuho raises Tenet Healthcare stock price target on strong results

Mizuho increased its price target for Tenet Healthcare (NYSE:THC) to $305 from $290, citing strong quarterly results and raised 2026 EBITDA estimates. The stock trades near its 52-week high after a 49% six-month surge. Tenet reported Q3 2026 EPS of $6.64, beating estimates, and raised its full-year EBITDA outlook. Guggenheim maintained a Buy rating with a slightly lowered target of $306.

$THCMed

Tenet Healthcare Q3 Earnings Call Highlights

Tenet Healthcare (THC) reported Q3 earnings, with hospital segment showing 3.2% growth in admissions and 11% adjusted EBITDA increase. Revenue per admission rose 0.2% YoY. Exchange admissions and revenues declined 18%. Conifer transition activities contributed $147M, with $450M expected in 2026. Tenet generated $1.1B in adjusted free cash flow and repurchased 970K shares.